{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:11:00Z","timestamp":1788768660258,"version":"build-2803163510"},"reference-count":298,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/14712598.2026.2646947","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:27:33Z","timestamp":1773757653000},"page":"285-319","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["A review of the clinical efficacy of monoclonal antibody (mAb)-based therapies for relapsed\/refractory multiple myeloma (RRMM)"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0623-2561","authenticated-orcid":false,"given":"Yuxin","family":"Liu","sequence":"first","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-4911","authenticated-orcid":false,"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Dong-A University College of Medicine","place":["Busan, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8190-2484","authenticated-orcid":false,"given":"Clifton C.","family":"Mo","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2958-1867","authenticated-orcid":false,"given":"Taya Jamal","family":"Salman","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6346-3376","authenticated-orcid":false,"given":"Shahrier","family":"Hossain","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-5507","authenticated-orcid":false,"given":"Shonali","family":"Midha","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-4277","authenticated-orcid":false,"given":"Omar","family":"Nadeem","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Croteau","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Kazierad","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1190-5978","authenticated-orcid":false,"given":"Tarek H.","family":"Mouhieddine","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-4218","authenticated-orcid":false,"given":"Poy","family":"Theprungsirikul","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7565-2052","authenticated-orcid":false,"given":"Jacob P.","family":"Laubach","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7426-8865","authenticated-orcid":false,"given":"Paul G.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,5]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.0023"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14514"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012640"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02515"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01041-x"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2024.2382897"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2024.11.012"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000001167"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-740944"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17213471"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01821"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1398902"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2024.104265"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0734-z"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05768-6"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6619"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2024.100025"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121632"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1174138"},{"key":"e_1_3_5_24_1","unstructured":"Janssen Biotech Inc. DARZALEX (daratumumab) injection for intravenous use - prescribing information. [cited 2025 Dec 5]. Available from: https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/DARZALEX-pi.pdf"},{"key":"e_1_3_5_25_1","unstructured":"Janssen Biotech Inc. DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection for subcutaneous use - prescribing information. [cited 2025 Dec 5]. Available from: https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/DARZALEX+Faspro-pi.pdf"},{"key":"e_1_3_5_26_1","unstructured":"Janssen-Cilag International NV. DARZALEX - Summary of product characteristics. [cited 2025 Dec 5]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/overview\/darzalex-epar-medicine-overview_en.pdf"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04917-5"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01771"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0855-4"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017006866"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2015-1031"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506348"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-705210"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30081-8"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16059"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15879"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-726729"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01814"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0711-6"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607751"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00940"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.194282"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16980"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.09.623"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606038"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02734"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.194118"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.04.012"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00128-5"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00218-1"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-785246"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2024.07.014"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2030477"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03338-4"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0813-1"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30734-0"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00579-9"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010026"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00805-x"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000722"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30070-3"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279459"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27382"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27206"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181091"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008866"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01296-8"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.122"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284089"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283490"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283509"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-180766"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174443"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2514663"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200181"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-205083"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029360"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31706"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-020-00137-x"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0842"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1177\/10781552211067780"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18172"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05188-4"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-207341"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18703"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.galenos.2023.2023.0029"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05443-8"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.08.017"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14193"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24883"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3209"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147627"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.68148"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011101"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024371"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02020"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40966-8"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18233"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17541"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-021-03204-9"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2076847"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15806"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03365-w"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S302682"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000667"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.243790"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01374-5"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-187487"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01893"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081261"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04978-6"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173896"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16292"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14413"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-703439"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010167"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02134"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024028107"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01096-6"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13942"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199085"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010162"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2025.2561117"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac574"},{"key":"e_1_3_5_125_1","unstructured":"Sanofi Winthrop Industrie. Sarclisa - Summary of product characteristics. [cited 2025 Dec 5]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/sarclisa-epar-product-information_en.pdf"},{"key":"e_1_3_5_126_1","unstructured":"sanofi-aventis U.S. LLC. SARCLISA (isatuximab-irfc) injection for intravenous use - prescribing information. [cited 2025 Dec 5]. Available from: https:\/\/products.sanofi.us\/Sarclisa\/sarclisa.pdf"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00744"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70041"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.01.022"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121522"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17101278"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-3192"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06343-9"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32556-5"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284325"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00019-5"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00797-8"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00592-4"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00148-0"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-740787"},{"issue":"1","key":"e_1_3_5_141_1","first-page":"892","article-title":"Isatuximab in combination with pomalidomide and dexamethasone in patients with multiple myeloma who relapsed after one line of lenalidomide-containing therapy: a phase 2 study by the Greek myeloma study group","volume":"9","author":"Terpos E","year":"2025","unstructured":"Terpos E, Gavriatopoulou M, Spyridonidis A, et al. Isatuximab in combination with pomalidomide and dexamethasone in patients with multiple myeloma who relapsed after one line of lenalidomide-containing therapy: a phase 2 study by the Greek myeloma study group. Hemasphere. 2025;9(S1):892\u2013893.","journal-title":"Hemasphere"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01262-w"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-02-895193"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284730"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181266"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7526"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-209597"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33448"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05975-7"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5753"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008209"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0857-2"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0198-4"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3105"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14657"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00478-4"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59186-1"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14225"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286658"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200165"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.287325"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-024-03904-y"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000738"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-206978"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14314"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18040595"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-0568"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106576"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0868-z"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17499"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.253450"},{"key":"e_1_3_5_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.04.005"},{"key":"e_1_3_5_173_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26319"},{"key":"e_1_3_5_174_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26602"},{"key":"e_1_3_5_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.11.005"},{"key":"e_1_3_5_176_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283073"},{"key":"e_1_3_5_177_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyac137"},{"key":"e_1_3_5_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2023.06.011"},{"key":"e_1_3_5_179_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03378-w"},{"key":"e_1_3_5_180_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279229"},{"key":"e_1_3_5_181_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13835"},{"key":"e_1_3_5_182_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3038"},{"key":"e_1_3_5_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.106948"},{"key":"e_1_3_5_184_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3258"},{"key":"e_1_3_5_185_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280660"},{"key":"e_1_3_5_186_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.287904"},{"key":"e_1_3_5_187_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2022.2028978"},{"key":"e_1_3_5_188_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02551"},{"key":"e_1_3_5_189_1","unstructured":"Bristol-Myers Squibb Company. EMPLICITI (elotuzumab) for injection for intravenous use - prescribing information. [cited 2025 Dec 5]. Available from: https:\/\/packageinserts.bms.com\/pi\/pi_empliciti.pdf"},{"key":"e_1_3_5_190_1","unstructured":"Bristol-Myers Squibb Pharma EEIG. Empliciti - Summary of product characteristics. [cited 2025 Dec 5]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/empliciti-epar-product-information_en.pdf"},{"key":"e_1_3_5_191_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505654"},{"key":"e_1_3_5_192_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14787"},{"key":"e_1_3_5_193_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31680"},{"key":"e_1_3_5_194_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00357-4"},{"key":"e_1_3_5_195_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805762"},{"key":"e_1_3_5_196_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02815"},{"key":"e_1_3_5_197_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-360552"},{"key":"e_1_3_5_198_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.2649"},{"key":"e_1_3_5_199_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00197-0"},{"key":"e_1_3_5_200_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14263"},{"key":"e_1_3_5_201_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01134-3"},{"key":"e_1_3_5_202_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.7069"},{"key":"e_1_3_5_203_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-694604"},{"key":"e_1_3_5_204_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014717"},{"key":"e_1_3_5_205_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2023.03.016"},{"key":"e_1_3_5_206_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7559"},{"key":"e_1_3_5_207_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.241513"},{"key":"e_1_3_5_208_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3031"},{"key":"e_1_3_5_209_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2487-23"},{"key":"e_1_3_5_210_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01310-z"},{"key":"e_1_3_5_211_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283251"},{"key":"e_1_3_5_212_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.104084"},{"key":"e_1_3_5_213_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49307"},{"key":"e_1_3_5_214_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.18"},{"key":"e_1_3_5_215_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05705-z"},{"key":"e_1_3_5_216_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2024.09.008"},{"key":"e_1_3_5_217_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30788-0"},{"key":"e_1_3_5_218_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00243-0"},{"key":"e_1_3_5_219_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405090"},{"key":"e_1_3_5_220_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403407"},{"key":"e_1_3_5_221_1","unstructured":"GlaxoSmithkline LLC. BLENREP (belantamab mafodotin-blmf) for injection for intravenous use - prescribing information. [cited 2025 Dec 5]. Available from: https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_US\/Prescribing_Information\/Blenrep\/pdf\/BLENREP-PI-MG.PDF"},{"key":"e_1_3_5_222_1","unstructured":"GlaxoSmithKline. Blenrep - Summary of product characteristics. [cited 2025 Dec 5]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/blenrep-epar-product-information_en.pdf"},{"key":"e_1_3_5_223_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.77"},{"key":"e_1_3_5_224_1","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.11.25335116"},{"key":"e_1_3_5_225_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.288203"},{"key":"e_1_3_5_226_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.06.015"},{"key":"e_1_3_5_227_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33809"},{"key":"e_1_3_5_228_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34987"},{"key":"e_1_3_5_229_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00369-0"},{"key":"e_1_3_5_230_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00330-4"},{"key":"e_1_3_5_231_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199282"},{"issue":"1","key":"e_1_3_5_232_1","first-page":"846","article-title":"(PF728) updated results from phase 3 DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone vs pomalidomide plus bortezomib and dexamethasone in relapsed\/refractory multiple myeloma","volume":"9","author":"Dimopoulos MA","year":"2025","unstructured":"Dimopoulos MA, Beksac M, Pour L, et al. (PF728) updated results from phase 3 DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone vs pomalidomide plus bortezomib and dexamethasone in relapsed\/refractory multiple myeloma. Hemasphere. 2025;9(S1):846\u2013847.","journal-title":"Hemasphere"},{"key":"e_1_3_5_233_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30576-X"},{"key":"e_1_3_5_234_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0196-6"},{"key":"e_1_3_5_235_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-211224"},{"issue":"1","key":"e_1_3_5_236_1","first-page":"858","article-title":"A multicenter phase 2 study designed to optimize the schedule of belantamab mafodotin plus bortezomib and dexamethasone in relapsed refractory multiple myeloma","volume":"9","author":"Popkov\u00e1 T","year":"2025","unstructured":"Popkov\u00e1 T, Radocha J, Stork M, et al. A multicenter phase 2 study designed to optimize the schedule of belantamab mafodotin plus bortezomib and dexamethasone in relapsed refractory multiple myeloma. Hemasphere. 2025;9(S1):858\u2013859.","journal-title":"Hemasphere"},{"key":"e_1_3_5_237_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-189005"},{"key":"e_1_3_5_238_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-205957"},{"key":"e_1_3_5_239_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01155-y"},{"key":"e_1_3_5_240_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02703-y"},{"key":"e_1_3_5_241_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204055"},{"key":"e_1_3_5_242_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35319"},{"key":"e_1_3_5_243_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14222"},{"key":"e_1_3_5_244_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285893"},{"key":"e_1_3_5_245_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112964"},{"key":"e_1_3_5_246_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18479"},{"key":"e_1_3_5_247_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281772"},{"key":"e_1_3_5_248_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2025.100103"},{"key":"e_1_3_5_249_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.70039"},{"key":"e_1_3_5_250_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01226-8"},{"issue":"1","key":"e_1_3_5_251_1","first-page":"2997","article-title":"Real-world effectiveness and safety of belantamab mafodotin (belamaf) monotherapy in patients (pts) with relapsed\/refractory multiple myeloma (RRMM) treated in Europe","volume":"9","author":"Cavo M","year":"2025","unstructured":"Cavo M, Dimopoulos MA, Delforge M, et al. Real-world effectiveness and safety of belantamab mafodotin (belamaf) monotherapy in patients (pts) with relapsed\/refractory multiple myeloma (RRMM) treated in Europe. Hemasphere. 2025;9(S1):2997\u20132999.","journal-title":"Hemasphere"},{"key":"e_1_3_5_252_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.907"},{"key":"e_1_3_5_253_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7546"},{"key":"e_1_3_5_254_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-025-01174-0"},{"key":"e_1_3_5_255_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7533"},{"key":"e_1_3_5_256_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-201543"},{"key":"e_1_3_5_257_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7515"},{"key":"e_1_3_5_258_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003596"},{"key":"e_1_3_5_259_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2025.1008"},{"key":"e_1_3_5_260_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.70015"},{"key":"e_1_3_5_261_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016949"},{"key":"e_1_3_5_262_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.10.003"},{"key":"e_1_3_5_263_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.05.019"},{"key":"e_1_3_5_264_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-025-00354-2"},{"key":"e_1_3_5_265_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaf148"},{"key":"e_1_3_5_266_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.12040"},{"key":"e_1_3_5_267_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7544"},{"key":"e_1_3_5_268_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(25)00256-X"},{"key":"e_1_3_5_269_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(25)00163-2"},{"key":"e_1_3_5_270_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14270"},{"key":"e_1_3_5_271_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012448"},{"key":"e_1_3_5_272_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199381"},{"key":"e_1_3_5_273_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7550"},{"issue":"1","key":"e_1_3_5_274_1","first-page":"233","article-title":"Talquetamab + cetrelimab in patients with relapsed\/refractory multiple myeloma: initial safety and efficacy results from the phase 1b TRIMM-3 study","volume":"9","author":"Perrot A","year":"2025","unstructured":"Perrot A, Touzeau C, Rodr\u00edguez-Otero P, et al. Talquetamab + cetrelimab in patients with relapsed\/refractory multiple myeloma: initial safety and efficacy results from the phase 1b TRIMM-3 study. Hemasphere. 2025;9(S1):233\u2013234.","journal-title":"Hemasphere"},{"key":"e_1_3_5_275_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0975"},{"key":"e_1_3_5_276_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.70072"},{"key":"e_1_3_5_277_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00799-7"},{"key":"e_1_3_5_278_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0287"},{"key":"e_1_3_5_279_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-210088"},{"key":"e_1_3_5_280_1","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3843028\/v1"},{"issue":"1","key":"e_1_3_5_281_1","first-page":"885","article-title":"The anti-BCMA antibody-drug conjugate HDP-101 with a novel amanitin payload shows promising data in relapsed\/refractory multiple myeloma in a phase 1\/2a clinical trial as it advances into cohort 7","volume":"9","author":"Richard S","year":"2025","unstructured":"Richard S, Orlowski RZ, Kaufman J, et al. The anti-BCMA antibody-drug conjugate HDP-101 with a novel amanitin payload shows promising data in relapsed\/refractory multiple myeloma in a phase 1\/2a clinical trial as it advances into cohort 7. Hemasphere. 2025;9(S1):885\u2013886.","journal-title":"Hemasphere"},{"key":"e_1_3_5_282_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-207816"},{"key":"e_1_3_5_283_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123464"},{"key":"e_1_3_5_284_1","doi-asserted-by":"publisher","DOI":"10.46989\/001c.141401"},{"key":"e_1_3_5_285_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02505-2"},{"key":"e_1_3_5_286_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409029"},{"key":"e_1_3_5_287_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.70373"},{"key":"e_1_3_5_288_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00217-X"},{"key":"e_1_3_5_289_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00282-1"},{"key":"e_1_3_5_290_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(25)03424-X"},{"key":"e_1_3_5_291_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17142398"},{"key":"e_1_3_5_292_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2025.09.003"},{"key":"e_1_3_5_293_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029921"},{"key":"e_1_3_5_294_1","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/1429879"},{"key":"e_1_3_5_295_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2505133"},{"key":"e_1_3_5_296_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312054"},{"key":"e_1_3_5_297_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01114-7"},{"key":"e_1_3_5_298_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(25)03406-8"},{"key":"e_1_3_5_299_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0141-0"},{"key":"e_1_3_5_300_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2025.2575570"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2646947","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14712598.2026.2646947","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2646947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:59:54Z","timestamp":1788767994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2026.2646947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":298,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/14712598.2026.2646947"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2026.2646947","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}